Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim

NCT01439321 · clinicaltrials.gov ↗

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenic Purpura

Interventions

BIOLOGICAL: Eltrombopag
BIOLOGICAL: Romiplostim

Sponsor

GlaxoSmithKline